November 13, 2026 · Blood · DOI: 10.1182/blood.2026036096

Optimizing Reduced-Intensity Conditioning for Older Patients with AML and MDS: A Large-Scale Analysis from the CIBMTR.

Listen to this summary

This CIBMTR registry study asked which fludarabine-based reduced-intensity conditioning regimen best serves patients aged 50 and older with AML or MDS undergoing allogeneic transplant. Across 11,731 patients, fludarabine-melphalan regimens (100 or 140 mg/m²) had higher early mortality than fludarabine-busulfan but achieved better late overall survival, lower relapse, and improved disease-free survival in the 2019-2022 cohort. The authors conclude that fludarabine-melphalan conditioning is preferred for this older population regardless of baseline comorbidities.

Piyanuch Kongtim, Andrew Jay Portuguese, Roni Shouval, Soyoung Kim, Andrew Peterson, Mariam Allbee-Johnson, Temitope Oloyede, Brent R Logan, Hany Elmariah, Lori S Muffly, Mark B Juckett, Michael R Grunwald, Mariam T Nawas, Nelli Bejanyan, Tania Jain, Veronika Bachanova, Xia Bi, Ryan J Stubbins, Sairah Ahmed, Seth J Rotz, Annie Im, Shatha Farhan, Poorva Bindal, Reena V Jayani Kosarzycki, Michelle L Schoettler, Hélène M Schoemans, Betty K Hamilton, Rachel Phelan, Ryotaro Nakamura, Betul Oran, Saurabh Chhabra, Edward Stadtmauer, Brandon Nuechterlein, Rebecca Higgins, Mohamed L Sorror, Amy Moskop, Arnon Nagler, Bipin N Savani, Wael Saber, Bart L Scott, Stefan O Ciurea

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play